Research Overview: YK-11 5mg Sterling Knight
YK-11 is a selective androgen receptor modulator (SARM) that has garnered significant attention in research circles for its unique myostatin inhibition properties. This Sterling Knight formulation provides researchers with a precisely dosed 5mg tablet format, enabling detailed investigation into muscle protein synthesis pathways and myostatin regulation mechanisms. The compound’s distinctive structure allows researchers to examine selective androgenic activity while investigating its potential as a myostatin follistatin pathway modulator. Scientists studying muscle wasting conditions and anabolic signaling cascades frequently select YK-11 for its dual-action profile in laboratory environments.
The Sterling Knight brand maintains rigorous quality standards, ensuring consistent research outcomes across multiple studies. When researchers at Stroid UK Shop require reliable SARM compounds, this formulation provides the analytical consistency necessary for peer-reviewed research protocols.
Laboratory Research Applications
Research institutions investigate YK-11’s unique mechanism of action through various in-vitro studies examining myostatin inhibition and androgenic receptor binding affinity. Laboratory protocols commonly examine this compound’s effects on satellite cell activation and muscle fiber development in controlled cellular environments. Scientists studying metabolic pathways analyse YK-11’s influence on protein synthesis rates and nitrogen retention mechanisms.
Comparative studies within the broader SARM research category demonstrate YK-11’s distinctive properties relative to other selective modulators. Research teams investigating muscle atrophy conditions examine this compound alongside other selective androgen receptor modulators to understand differential binding mechanisms and downstream signaling effects.
Advanced research protocols often combine YK-11 studies with investigations into peptide-based growth factors to examine synergistic cellular responses and pathway interactions in muscle tissue development.
Technical Specifications
| Parameter | Specification |
|---|---|
| Compound Name | YK-11 |
| Dosage per Tablet | 5mg |
| Form | Oral Tablet |
| Manufacturer | Sterling Knight |
| Purity | ≥98% |
| CAS Number | 1370003-76-1 |
| Molecular Formula | C25H34O6 |
| Molecular Weight | 430.54 g/mol |
| Storage | Room temperature, dry conditions |
Research Compliance Statement
This YK-11 5mg Sterling Knight product is manufactured exclusively for in-vitro research applications and laboratory analysis. This compound is not intended for human consumption, therapeutic use, or any application outside controlled research environments. Researchers must ensure compliance with institutional guidelines and regulatory requirements when conducting studies with this material.

